Dr Lance James Doeden, MD | |
1720 University Dr S, Fargo, ND 58103-4940 | |
(701) 234-7400 | |
Not Available |
Full Name | Dr Lance James Doeden |
---|---|
Gender | Male |
Speciality | Pain Management |
Experience | 12 Years |
Location | 1720 University Dr S, Fargo, North Dakota |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1952659773 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208VP0014X | Pain Medicine - Interventional Pain Medicine | 11490 (North Dakota) | Secondary |
208VP0000X | Pain Medicine - Pain Medicine | 11490 (North Dakota) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Black Hills Surgical Hospital Llp | Rapid city, SD | Hospital |
Monument Health Rapid City Hospital | Rapid city, SD | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Rapid City Medical Center Llp | 5890691075 | 87 |
News Archive
Centerphase has entered into a collaboration with Mayo Clinic to speed the introduction of new medical treatments developed by the biopharmaceutical industry. The Company addressed the root causes historically plaguing the clinical trials process: the lack of a systematic, structured approach for evaluating and optimizing protocols and the tremendous burdens associated with trial start-up administration.
Gold Standard Diagnostics (GSD) today announced FDA clearance of its next-generation Lyme disease Line Immunoassay which offers excellent specificity and sensitivity at any disease stage.
Dr. Martin Hickey, Chairman of the National Alliance of State Health CO-OPs' Board of Directors, made the following statement regarding the recent announcement that the Iowa Insurance Division is taking over CoOportunity Health.
BioTrends Research Group, Inc. and the National Kidney Foundation announce the publication of a Special Report: Patient Perspectives in Dialysis and Chronic Kidney Disease. This important new syndicated study provides insights into patients with kidney disease, from the patients themselves. Over 1,100 patients in the U.S. - both those on dialysis and those with mid-late stage chronic kidney disease - completed a survey about living with CKD.
› Verified 5 days ago
Entity Name | Rapid City Medical Center Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1558373845 PECOS PAC ID: 5890691075 Enrollment ID: O20031209000567 |
News Archive
Centerphase has entered into a collaboration with Mayo Clinic to speed the introduction of new medical treatments developed by the biopharmaceutical industry. The Company addressed the root causes historically plaguing the clinical trials process: the lack of a systematic, structured approach for evaluating and optimizing protocols and the tremendous burdens associated with trial start-up administration.
Gold Standard Diagnostics (GSD) today announced FDA clearance of its next-generation Lyme disease Line Immunoassay which offers excellent specificity and sensitivity at any disease stage.
Dr. Martin Hickey, Chairman of the National Alliance of State Health CO-OPs' Board of Directors, made the following statement regarding the recent announcement that the Iowa Insurance Division is taking over CoOportunity Health.
BioTrends Research Group, Inc. and the National Kidney Foundation announce the publication of a Special Report: Patient Perspectives in Dialysis and Chronic Kidney Disease. This important new syndicated study provides insights into patients with kidney disease, from the patients themselves. Over 1,100 patients in the U.S. - both those on dialysis and those with mid-late stage chronic kidney disease - completed a survey about living with CKD.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Lance James Doeden, MD 1720 University Dr S, Fargo, ND 58103-4940 Ph: (701) 234-7400 | Dr Lance James Doeden, MD 1720 University Dr S, Fargo, ND 58103-4940 Ph: (701) 234-7400 |
News Archive
Centerphase has entered into a collaboration with Mayo Clinic to speed the introduction of new medical treatments developed by the biopharmaceutical industry. The Company addressed the root causes historically plaguing the clinical trials process: the lack of a systematic, structured approach for evaluating and optimizing protocols and the tremendous burdens associated with trial start-up administration.
Gold Standard Diagnostics (GSD) today announced FDA clearance of its next-generation Lyme disease Line Immunoassay which offers excellent specificity and sensitivity at any disease stage.
Dr. Martin Hickey, Chairman of the National Alliance of State Health CO-OPs' Board of Directors, made the following statement regarding the recent announcement that the Iowa Insurance Division is taking over CoOportunity Health.
BioTrends Research Group, Inc. and the National Kidney Foundation announce the publication of a Special Report: Patient Perspectives in Dialysis and Chronic Kidney Disease. This important new syndicated study provides insights into patients with kidney disease, from the patients themselves. Over 1,100 patients in the U.S. - both those on dialysis and those with mid-late stage chronic kidney disease - completed a survey about living with CKD.
› Verified 5 days ago
Majid Ghazi, MD Pain Medicine Medicare: May Accept Medicare Assignments Practice Location: 2401 41st St S, Fargo, ND 58104 Phone: 701-551-6980 Fax: 701-551-6984 |